Turn Therapeutics Inc.
TTRX
$6.93
$0.111.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -447.90% | 114.66% | -- | -- | -1.67% |
| Total Depreciation and Amortization | 2.11% | 3.65% | -- | -- | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.77% | -5,689.09% | -- | -- | 574.95% |
| Change in Net Operating Assets | -200.63% | -41.97% | -- | -- | -83.16% |
| Cash from Operations | -38.81% | -99.85% | -47.52% | -33.85% | 30.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.15% | 65.03% | -- | -- | -- |
| Cash from Investing | 61.15% | 65.03% | -464.78% | 0.00% | -103.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -66.33% | 434.43% | -- | -- | 91.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 145.04% | 434.43% | -62.21% | 57.66% | 91.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 211.75% | 2,450.84% | -107.23% | 65.53% | 735.32% |